Bone Loss Drugs Increase Stroke Risk in Patients With Cancer

Publication
Article
Oncology Nursing NewsDecember 2010
Volume 4
Issue 6

Older patients with cancer taking bisphosphonates for bone metastases are at modestly increased risk

Older patients with cancer taking bisphosphonates for bone metastases are at modestly increased risk for atrial fibrillation and stroke. According to a study published online in the Journal of Clinical Oncology, the absolute risk for these patients within 6 years of starting bisphosphonate treatment was approximately 8% for all supraventricular tachycardia events and 4% for stroke.

Related Content
© 2024 MJH Life Sciences

All rights reserved.